9-2622260-C-A

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2

The NM_003383.5(VLDLR):​c.71C>A​(p.Ala24Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000398 in 1,491,290 control chromosomes in the GnomAD database, including 4 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.00047 ( 1 hom., cov: 33)
Exomes 𝑓: 0.00039 ( 3 hom. )

Consequence

VLDLR
NM_003383.5 missense

Scores

1
3
15

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:4

Conservation

PhyloP100: 2.35

Publications

2 publications found
Variant links:
Genes affected
VLDLR (HGNC:12698): (very low density lipoprotein receptor) The low density lipoprotein receptor (LDLR) gene family consists of cell surface proteins involved in receptor-mediated endocytosis of specific ligands. This gene encodes a lipoprotein receptor that is a member of the LDLR family and plays important roles in VLDL-triglyceride metabolism and the reelin signaling pathway. Mutations in this gene cause VLDLR-associated cerebellar hypoplasia. Alternative splicing generates multiple transcript variants encoding distinct isoforms for this gene. [provided by RefSeq, Aug 2009]
VLDLR-AS1 (HGNC:49621): (VLDLR antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.011275977).
BP6
Variant 9-2622260-C-A is Benign according to our data. Variant chr9-2622260-C-A is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 366359.We mark this variant Likely_benign, oryginal submission is: [Conflicting_classifications_of_pathogenicity].
BS2
High Homozygotes in GnomAdExome4 at 3 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
VLDLRNM_003383.5 linkc.71C>A p.Ala24Asp missense_variant Exon 1 of 19 ENST00000382100.8 NP_003374.3 P98155-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
VLDLRENST00000382100.8 linkc.71C>A p.Ala24Asp missense_variant Exon 1 of 19 1 NM_003383.5 ENSP00000371532.2 P98155-1

Frequencies

GnomAD3 genomes
AF:
0.000473
AC:
72
AN:
152108
Hom.:
1
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.0170
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000118
Gnomad OTH
AF:
0.00239
GnomAD2 exomes
AF:
0.00120
AC:
109
AN:
91096
AF XY:
0.00119
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.0143
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000319
Gnomad OTH exome
AF:
0.00145
GnomAD4 exome
AF:
0.000390
AC:
522
AN:
1339182
Hom.:
3
Cov.:
34
AF XY:
0.000405
AC XY:
267
AN XY:
659990
show subpopulations
African (AFR)
AF:
0.0000366
AC:
1
AN:
27350
American (AMR)
AF:
0.00
AC:
0
AN:
30732
Ashkenazi Jewish (ASJ)
AF:
0.0165
AC:
391
AN:
23636
East Asian (EAS)
AF:
0.00
AC:
0
AN:
30798
South Asian (SAS)
AF:
0.00
AC:
0
AN:
73762
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
33096
Middle Eastern (MID)
AF:
0.000213
AC:
1
AN:
4684
European-Non Finnish (NFE)
AF:
0.0000633
AC:
67
AN:
1059146
Other (OTH)
AF:
0.00111
AC:
62
AN:
55978
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
28
56
84
112
140
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000473
AC:
72
AN:
152108
Hom.:
1
Cov.:
33
AF XY:
0.000498
AC XY:
37
AN XY:
74306
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
41432
American (AMR)
AF:
0.00
AC:
0
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
0.0170
AC:
59
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5138
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4832
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10624
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.000118
AC:
8
AN:
68006
Other (OTH)
AF:
0.00239
AC:
5
AN:
2092
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
4
8
13
17
21
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00218
Hom.:
0
Bravo
AF:
0.000484
TwinsUK
AF:
0.000539
AC:
2
ALSPAC
AF:
0.000519
AC:
2
ExAC
AF:
0.000367
AC:
32

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:4
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Benign:2
Mar 25, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Mar 24, 2021
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Congenital cerebellar hypoplasia Uncertain:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
Sep 30, 2021
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Cerebellar ataxia, intellectual disability, and dysequilibrium syndrome 1 Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.10
BayesDel_addAF
Benign
-0.13
T
BayesDel_noAF
Benign
-0.13
CADD
Benign
23
DANN
Uncertain
0.99
DEOGEN2
Benign
0.13
T;T;.
Eigen
Benign
-0.32
Eigen_PC
Benign
-0.13
FATHMM_MKL
Benign
0.61
D
LIST_S2
Benign
0.68
T;T;T
M_CAP
Pathogenic
0.95
D
MetaRNN
Benign
0.011
T;T;T
MetaSVM
Benign
-0.31
T
MutationAssessor
Benign
0.0
N;.;N
PhyloP100
2.4
PrimateAI
Uncertain
0.67
T
PROVEAN
Benign
-1.2
N;N;N
REVEL
Benign
0.19
Sift
Uncertain
0.019
D;T;D
Sift4G
Benign
0.23
T;T;T
Polyphen
0.037
B;.;B
Vest4
0.26
MutPred
0.30
Gain of disorder (P = 0.0745);Gain of disorder (P = 0.0745);Gain of disorder (P = 0.0745);
MVP
0.82
MPC
0.15
ClinPred
0.061
T
GERP RS
4.2
PromoterAI
0.041
Neutral
Varity_R
0.40
gMVP
0.25
Mutation Taster
=94/6
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs754340855; hg19: chr9-2622260; API